Road to approval for US biotech crops in China beset with massive delays, costing industry billions
April 15, 2019 at 07:00 AM EDT
China's approval process for biotech crops is beset by regulatory hurdles and delays that have cost U.S. companies billions of dollars and added to challenges for American farmers.